Article | September 23, 2025

Utilizing A Site Network To Increase Participant Diversity & Reach

GettyImages-1169621483-injection-arm-line-trial

Community-based site networks are emerging as powerful agents for improving healthcare equity in clinical trials by embedding research directly within underserved populations and diverse communities. Unlike traditional centralized trial sites, these community-embedded sites have a unique ability to engage patients across diverse geographic and socio-ethnic backgrounds, significantly broadening access to clinical research. By leveraging trusted local relationships and culturally competent practices, community-based networks reduce barriers that have historically limited participation by underrepresented groups.

This paradigm shift in trial site utilization is transforming clinical research by making it more patient-centric and equitable, ensuring that study populations better reflect real-world diversity. As a result, therapies developed through these networks are more likely to be effective across varied patient populations. This model fosters collaboration between sponsors, investigators, and communities, ultimately driving trial success and accelerating the development of innovative treatments that serve all patients more effectively.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

MRN - Medical Research Network